Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

Yuko Tanabe, Kenji Hashimoto, Chikako Shimizu, +9

International Journal of Clinical Oncology

Breast OncologyOncologyPharmacologyAdjuvant ChemotherapyBreast Cancer +4

Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

R. Wendel Naumann, Ana Oaknin, Tim Meyer, +17

Annals of Oncology

Checkmate 358Cervical CancerMedicineCancer ManagementGynecology +5

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano, +116

The Lancet Oncology

Gynecological SurgeryMedicineMetronomic TherapyGynecologyRecurrent Endometrial Cancer +4

TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)

Akihito Kawazoe, Kota Itahashi, Noboru Yamamoto, +14

Clinical Cancer Research

Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

Kenichi Harano, Akihiro Hirakawa, Mayu Yunokawa, +12

International Journal of Clinical Oncology

Prognostic FactorsGynecological SurgeryMedicineCancer ManagementMulti-institutional Retrospective Study +7

Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)

Kuniko Sunami, Hideaki Takahashi, Katsuya Tsuchihara, +34

Cancer Science

Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer

Kenichi Harano, Xiudong Lei, Ana M. González-Angulo, +6

Breast Cancer Research and Treatment

Surgical OncologyBreast OncologyMedicinePathologyLong-term Survival +7

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

Kenichi Harano, Ying Wang, Bora Lim, +14

PLoS ONE

Breast OncologyImmunologyImmunoeditingPathologyImmunotherapy +15

MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer

Lei Huo, Yan Wang, Yun Gong, +19

Modern Pathology

Breast OncologyMicrorna ExpressionMedicineInflammatory Breast CancerCancer Genomics +7

LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma

Nicoletta Colombo, Kenichi Harano, Emma Hudson, +17

Annals of Oncology

MedicineGynecologyLba40 Phase IiiCancer TreatmentAdvanced/recurrent Endometrial Carcinoma +5